USP30 Inhibitor (Mission Therapeutics)

N/A

Report date: 2025/01/26 16:13:53
NME

Base Information

Drug NameUSP30 Inhibitor (Mission Therapeutics)
Drug Alias Namedeubiquitylating enzyme inhibitors (Mission Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 30
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMission Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMission Therapeutics
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A